Vaccines can play key role in combatting the spread of resistance, yet they have been a historically under recognized as a tool for fighting AMR. Hear from biotechs, pharmaceutical companies and funders on both the integration of vaccines into AMR strategies, as well as innovative vaccine development.
Antibiotic manufacturing has several key components impacting the spread of resistance: product quality, waste management and sustainable supply chains. These key elements affect both the efficiency for the manufacturer and also the spread of antimicrobial waste in the environment. Hear from large pharma, generic manufacturers, biotechs, and CMOs/CDMOs on how to improve manufacturing processes to
prevent antimicrobial resistance.